A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer

NCT01630733 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

664

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: Custirsen
DRUG: Docetaxel

Sponsor

Achieve Life Sciences